NM_001100916.2:c.344+1243G>T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001100916.2(MBOAT4):c.344+1243G>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000219 in 1,551,652 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001100916.2 intron
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MBOAT4 | ENST00000320542.4 | c.344+1243G>T | intron_variant | Intron 2 of 2 | 1 | NM_001100916.2 | ENSP00000314196.3 | |||
LEPROTL1 | ENST00000523116.5 | c.297C>A | p.Phe99Leu | missense_variant | Exon 4 of 4 | 2 | ENSP00000428281.1 | |||
LEPROTL1 | ENST00000442880.6 | c.412C>A | p.Leu138Ile | missense_variant | Exon 5 of 5 | 2 | ENSP00000412803.2 | |||
LEPROTL1 | ENST00000520739.5 | n.280-26822C>A | intron_variant | Intron 3 of 5 | 4 | ENSP00000429398.1 |
Frequencies
GnomAD3 genomes AF: 0.0000460 AC: 7AN: 152206Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000325 AC: 5AN: 153952Hom.: 0 AF XY: 0.0000490 AC XY: 4AN XY: 81684
GnomAD4 exome AF: 0.0000193 AC: 27AN: 1399328Hom.: 1 Cov.: 31 AF XY: 0.0000203 AC XY: 14AN XY: 690178
GnomAD4 genome AF: 0.0000460 AC: 7AN: 152324Hom.: 0 Cov.: 32 AF XY: 0.0000403 AC XY: 3AN XY: 74490
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.297C>A (p.F99L) alteration is located in exon 4 (coding exon 4) of the LEPROTL1 gene. This alteration results from a C to A substitution at nucleotide position 297, causing the phenylalanine (F) at amino acid position 99 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at